A Case of Long-term Survival of 36 Months in the Setting of Extensive-disease Small-cell Lung Cancer
Open Access
- 9 September 2019
- journal article
- research article
- Published by Springer Nature in Cureus
- Vol. 11 (9) , e5605
Abstract
Small-cell lung cancer (SCLC) is an extremely aggressive disease characterized by early regional spread and distant metastases. Patients with extensive-disease (ED) SCLC have a median survival rate of 8-11 months. Despite high response rates to initial therapy, relapses are frequent. Systemic therapy after the first-line failure remains vital in the treatment paradigm of SCLC. The National Comprehensive Cancer Network (NCCN) guidelines dictate that previously administered first-line chemotherapy can be used in relapses that occur after six months from the completion of initial therapy. For relapses within six months of initial therapy, sequential treatment with single agents is recommended. In this report, we discuss the case of a long-term SCLC survivor with an ED. The patient underwent several lines of chemotherapy and prophylactic cranial irradiation (PCI) and survived for 36 months.Keywords
This publication has 13 references indexed in Scilit:
- Management of immune related adverse events induced by immune checkpoint inhibitionCancer Letters, 2019
- Comparison and discussion of the treatment guidelines for small cell lung cancerThoracic Cancer, 2018
- Classification of pulmonary neuroendocrine tumors: new insightsTranslational Lung Cancer Research, 2017
- Optimal drugs for second-line treatment of patients with small-cell lung cancerExpert Opinion on Pharmacotherapy, 2016
- Use of thoracic radiotherapy for extensive stage small-cell lung cancer: a phase 3 randomised controlled trialThe Lancet, 2015
- Mutational heterogeneity in cancer and the search for new cancer-associated genesNature, 2013
- Bronchopulmonary neuroendocrine tumorsCancer, 2008
- Small Cell Lung Cancer: Have We Made Any Progress Over the Last 25 Years?The Oncologist, 2007
- Typical and Atypical Pulmonary Carcinoid Tumor Overdiagnosed as Small-Cell Carcinoma on Biopsy SpecimensAmerican Journal of Surgical Pathology, 2005
- Staging small cell lung cancer: Veterans Administration Lung Study Group versus International Association for the Study of Lung Cancer—what limits limited disease?Lung Cancer, 2002